ArticleBMJ open2022

Epicardial injection of allogeneic human-induced-pluripotent stem cell-derived cardiomyocytes in patients with advanced heart failure: protocol for a phase I/IIa dose-escalation clinical trial.

He Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.